Anastrozole for the prevention of breast cancer in high-risk postmenopausal women: cost-effectiveness analysis in the UK and the USA
Abstract Purpose The effectiveness of anastrozole for breast cancer prevention has been demonstrated. The objective of this study was to evaluate the cost-effectiveness of anastrozole for the prevention of breast cancer in women with a high risk of breast cancer and to determine whether anastrozole...
Main Authors: | XiaoXia Wei, Jiaqin Cai, Huiting Lin, Wenhua Wu, Jie Zhuang, Hong Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | BMC Health Services Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12913-024-10658-0 |
Similar Items
-
Postmarketing assessment of a switchable similar anastrozole product in Brazilian breast cancer patients
by: Manuela Vasquez Cardoso, et al.
Published: (2023-04-01) -
Anastrozole-Induced Dermatitis: Report of a Woman with an Anastrozole-Associated Dermatosis and a Review of Aromatase Inhibitor-Related Cutaneous Adverse Events
by: Yoo Jung Kim, et al.
Published: (2020-01-01) -
Locomotion Outcome Improvement in Mice with Glioblastoma Multiforme after Treatment with Anastrozole
by: Irene Guadalupe Aguilar-García, et al.
Published: (2023-03-01) -
Antiplatelet Therapy Combined with Anastrozole Induces Features of Partial EMT in Breast Cancer Cells and Fails to Mitigate Breast-Cancer Induced Hypercoagulation
by: Kutlwano R. Xulu, et al.
Published: (2021-04-01) -
Joint symptoms associated with anastrozole and letrozole in patients with breast cancer: a retrospective comparative study
by: Yoshihito Morimoto, et al.
Published: (2017-11-01)